Recruiting NCT06484179
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Targeted Self-Help, Usual Care.
- Who it may be relevant to
- Registry conditions: Cancer, Smoking. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type: A Pilot Randomized Control Trial (RCT)
Overview
The purpose of this research study is assess feasibility and acceptability of a recently developed brief self-help intervention targeted by cancer type to increase motivation to quit smoking.
Interventions
- Behavioral Targeted Self-Help
In addition to usual care participants will receive a self-help booklet specific for their cancer type. There are five booklets available, written at a 5-6th grade reading level and targeted by cancer type, that explain the connection between smoking and each cancer type, describe the benefits of quitting smoking after cancer, and address some of the barriers cancer patients face to quit smoking when fighting cancer. Each booklet also includes four testimonials inspired from conversations with p - Behavioral Usual Care
Participants will receive the standard care typically offered for smoking cessation.
Primary outcome measures
- Recruitment [Time frame: Baseline]
- Retention- Completion of 2-week follow-up [Time frame: 2 weeks post-randomization]
- Retention- Completion of 1 month follow-up [Time frame: 1 month post-randomization]
- Adherence- 2 weeks post-randomization [Time frame: 2 weeks post-randomization]
- Adherence- 1 month post-randomization [Time frame: 1 month post-randomization]
- Acceptability [Time frame: 2 weeks post-randomization, 1 month post-randomization]
Secondary outcome measures (4)
- Motivation to quit smoking [Time frame: Baseline, 2 weeks post-randomization, 1 month post-randomization]
- Treatment Engagement defined by the number of participants who enroll with the state tobacco quitline [Time frame: 2 weeks post-randomization, 1 month post-randomization]
- Smoking Status [Time frame: 2 weeks post-randomization, 1 month post-randomization]]
- Smoking Status [Time frame: 2 weeks post-randomization, 1 month post-randomization]
Eligibility criteria
Inclusion criteria
- Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per cancer type). (Investigators will consider smokers individuals who report having smoked ≥1 cigarette in the past 30 days.)
- Able to read/write English;
- Able to give informed consent;
- Not currently enrolled in a smoking cessation program;
- Age ≥18 years old.
Exclusion criteria
- Male patients diagnosed with breast cancer will be excluded as lifetime risk for breast cancer in men is far below 1%
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
United States · 1 center
- Huntsman Cancer Institute — Salt Lake City
Identifiers
NCT: NCT06484179 · HCI173619 · K22CA276255-01